Extracorporeal shockwave therapy (ESWT) uses high-energy acoustic waves generated outside the body and focused on specific target tissues. Originally developed for kidney stone fragmentation (lithotripsy), shockwave technology was adapted for musculoskeletal applications after physicians observed that patients with kidney stones also experienced improvement in concurrent orthopedic conditions.
Shockwave pulses create controlled microtrauma in the target tissue, which triggers the body’s natural healing response. This includes neovascularization (new blood vessel formation), recruitment of stem cells, increased growth factor production, and dissolution of calcific deposits. The mechanical energy also directly disrupts pain-transmitting nerve fibers, providing immediate analgesic effects.